Search Browse Earnings

ARS Pharmaceuticals, Inc. — SlamSEC

ARS Pharmaceuticals, Inc.

Nasdaq:SPRY

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$89.1M

+297063.3% YoY

FY 2025

Adj. EBITDA

-$3.0M

-3.4% margin

FY 2025

Net Income

$8.0M

9.0% margin

FY 2025

EPS (Diluted)

$0.08

FY 2025

Stock Price

$9.05

-0.1%

2026-03-09

52W Range

$6.66 – $18.90

P/E Ratio

113.1x

Market Cap

$898.6M

Cash

$50.8M

FY 2025

Total Debt

$3.5M

FY 2025

Net Cash

$47.3M

FY 2025

Enterprise Value

$851.3M

Debt / EBITDA

15.8x

FY 2025

EV / EBITDA

-283.4x

Employees

—